Fig. 6From: The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancerPredictive performance of the metabolic parameters in the identification of prognosisBack to article page
